Innoviva
INVA
$12.99
Share price
-1.81%
Change (1 day)
-8.84%
Change (1 year)
Categories
Revenue for Innoviva (INVA)
Revenue in 2023 (TTM): $0.29 B
According to Innoviva's latest financial reports the company's current revenue (TTM) is $0.29 B. In 2022 the company made a revenue of $0.33 B a decrease over the years 2021 revenue that were of $0.39 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Innoviva from 2005 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.29 B | -12.35% |
| 2022 | $0.33 B | -15.45% |
| 2021 | $0.39 B | 16.35% |
| 2020 | $0.33 B | 29.03% |
| 2019 | $0.26 B | 0% |
| 2018 | $0.26 B | 20.16% |
| 2017 | $0.21 B | 62.63% |
| 2016 | $0.13 B | 147.58% |
| 2015 | $53.94 M | 475.27% |
| 2014 | $9.37 M | 97.1% |
| 2013 | $4.75 M | -96.5% |
| 2012 | $0.13 B | 453.82% |
| 2011 | $24.51 M | 1.2% |
| 2010 | $24.22 M | -0.62% |
| 2009 | $24.37 M | 5.53% |
| 2008 | $23.09 M | 4.97% |
| 2007 | $22 M | 12.33% |
| 2006 | $19.58 M | 62.49% |
| 2005 | $12.05 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.86 B | 198.93% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | -99.92% | 🇺🇸 USA |